BioMedNewsBreaks – Safety Shot Inc. (NASDAQ: SHOT) to Serve as Official Title Sponsor of ‘A Special Private Evening with Luke Bryan’

Safety Shot (NASDAQ: SHOT) today announced that it is the official title sponsor of Save Our Musicians event, “A Special Private Evening with Luke Bryan.” At the charity concert event taking place on Nov. 18, 2023, in Jupiter, Florida, country superstar and American Idol judge Luke Bryan will be performing to raise money for the arts in public schools. The concert follows a similar successful Save Our Musicians fundraiser featuring Gwen Stefani, which also raised funds for arts education and garnered over 3 million views on social media. The Safety Shot brand and logo will be prominent on the event’s ticking page, and concert goers will be treated to free samples of Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. “We are so proud to sponsor this charity event, right in Safety Shot’s home town in Jupiter, Florida. Luke Bryan, a country music icon, represents the best of America,” said Safety Shot’s CEO Brian John. “We look forward to introducing Safety Shot to concert goers at the upcoming event and believe Safety Shot will appeal to Luke’s fans across the U.S. who may view the concert across digital platforms.”

To view the full press release, visit https://ibn.fm/gXorG

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented beverage on Earth that helps people feel better faster by reducing blood alcohol content and boosting clarity. Safety Shot will be available for retail purchase in the first week of December 2023 at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN